they stated the direction that they are going in with the new lab.
“As we advance our cellular therapeutic products, the need for flexibility and manufacturing has become more and more apparent. By controlling our own manufacturing, we believe the Company is in a significantly better position to advance its objectives and reduce costs of production” said Timothy Dixon
Allogen Biologics will house intellectual property and Standard Operating Procedures related to generation of the Company’s existing and anticipated cellular therapeutics.
News 
Market Data 
Discover 
AI
